Beclomethasone

Beclomethasone

SCHEMBL5037573

CC1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(Cl)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 9/20 1.00
CYP3A4 P08684 7/20 1.00
NR3C1 P04150 7/20 1.00
NFKB1 P19838 4/20 1.00
LMNA P02545 3/20 1.00
ABCB11 O95342 2/20 1.00
BLM P54132 2/20 1.00
MAPT P10636 1/20 1.00
GAA P10253 1/20 1.00
SMN1; SMN2 Q16637 1/20 1.00
HSD17B10 Q99714 4/20 0.77
PGR P06401 4/20 0.77
AR P10275 3/20 0.77
TSHR P16473 2/20 0.77
PMP22 Q01453 2/20 0.77
MEN1 O00255 1/20 0.77
CYP2D6 P10635 1/20 0.77
KMT2A Q03164 1/20 0.77
APEX1 P27695 1/20 0.77
NPSR1 Q6W5P4 1/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Beclomethasone SCHEMBL5037570 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA
Beclomethasone SCHEMBL7755941 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA
Beclomethasone SCHEMBL1462741 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA
Beclomethasone SCHEMBL18762039 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA
Beclomethasone SCHEMBL13046625 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA
Beclomethasone SCHEMBL8809468 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA
Beclomethasone SCHEMBL3183 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA
Beclomethasone SCHEMBL7614763 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA
Beclomethasone SCHEMBL5486743 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA
Beclomethasone SCHEMBL5486747 1.00 HIF1A (1.00) HIF1ACYP3A4NR3C1NFKB1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1143950-B1 TOPICAL APPLICATION PRODUCTS AGAINST ONYCHOMYCOSES BIOEQUAL AG (CH) 2005-03-09 EP claimed
EP-1680076-B1 PHARMACEUTICAL AND COSMETIC FORMULATIONS FOR TREATING FINGERNAILS BIOEQUAL AG (CH) 2008-07-02 EP disclosed
US-20070166249-A1 Pharmaceutical and cosmetic formulations for treating fingernails BIOEQUAL AG (CH) 2007-07-19 US disclosed
EP-1143950-B1 TOPICAL APPLICATION PRODUCTS AGAINST ONYCHOMYCOSES BIOEQUAL AG (CH) 2005-03-09 EP disclosed
US-6740326-B1 WATER-FREE TOPICAL APPLICATION COMPOSITION FOR TREATMENT OF NAIL DISEASES AND NAIL CARE CONSISTING OF ANTIMYCOTIC AGENT AND LOWER ALKYL ESTER OF LACTIC ACID, MALIC ACID, TARTARIC ACID OR CITRIC ACID AS PENETRATION PROMOTING CARRIER BIOEQUAL AG (CH) 2004-05-25 US disclosed
EP-0902789-B1 ANDROSTENE DERIVATIVES SOFT DRUGS INC (US) 2002-01-23 EP disclosed
US-4377575-A Corticoid-17-(alkyl carbonates) and process for their manufacture HOECHST AKTIENGESELLSCHAFT (DE) 1983-03-22 US disclosed
EP-0000742-B1 CORTICOIDS-17-ALKYLCARBONATES, PROCESS FOR THEIR PREPARATION AND PREPARATIONS CONTAINING THEM HOECHST AKTIENGESELLSCHAFT (DE) 1982-05-12 EP disclosed
US-4242334-A ANTIINFLAMMATORY AGENTS; SKIN DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1980-12-30 US disclosed
EP-0004975-A2 17-Alkylcarbonates of corticoids, process for their preparation and their use as medicines against dermatoses HOECHST AKTIENGESELLSCHAFT (DE) 1979-10-31 EP disclosed
EP-0000742-A1 Corticoids-17-alkylcarbonates, process for their preparation and preparations containing them HOECHST AKTIENGESELLSCHAFT (DE) 1979-02-21 EP disclosed
US-4024131-A ANTIINFLAMMATORY PLURICHEMIE ANSTALT (FL) 1977-05-17 US disclosed